Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Biostar Pharmaceuticals, Inc.Financial_Report.xls
EX-31.2 - EX-31.2 - Biostar Pharmaceuticals, Inc.ex31-2.htm
EX-31.1 - EX-31.1 - Biostar Pharmaceuticals, Inc.ex31-1.htm
EX-32.1 - EX-32.1 - Biostar Pharmaceuticals, Inc.ex32-1.htm
10-Q - 10-Q - Biostar Pharmaceuticals, Inc.biostarpharma093014.htm
Exhibit 32.2

CERTIFICATION
 
In connection with the periodic report of Biostar Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2014, as filed with the Securities and Exchange Commission (the “Report”), I, Qinghua Liu, Chief Financial Officer (Principal Financial and Accounting Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:
 
 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and

 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.
 
Date:   November 14, 2014
/s/Qinghua Liu                                                        
 
 
Qinghua Liu, Interim Chief Financial Officer
 
 
(Principal Financial and Accounting Officer)
 

A signed original of this written statement has been provided to the Registrant and will be retained by the Registrant and to the Securities and Exchange Commission or its staff upon request.